Results reported here are relevant to the biology of DUX4 and could have an immediate impact on the basic knowledge and potential pathogenic role of DUX4 in FSHD, as well as on the future rational therapeutic approaches to cure FSHD. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.